Literature DB >> 2412191

Antinociceptive and neurotoxic actions of substance P analogues in the rat's spinal cord after intrathecal administration.

C Post, I Paulsson.   

Abstract

Intrathecal administration of both (D-Pro2,D-Trp7,9)-substance P (DPDT) and (D-Arg1,D-Trp7,9,Leu11)-substance P (DADTL) elicited antinociception in hot-plate and tail-flick test, with DADTL as the most potent. The animals injected with 2.0 micrograms DADTL, and several animals administered with DPDT at the same dose, developed bilateral motor blockade of the hind-legs, persisting for up to 3 days after DADTL. The effect of DPDT appeared to be reversible at this dose. On histopathological examination it was found that these animals with persistent paralysis had widespread neuronal necrosis in the lumbar region of the spinal cord. It is concluded that the peptides have antinociceptive effects after the intrathecal administration in rats, but that there is a small margin between the dose producing this effect and that causing irreversible toxic reactions in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412191     DOI: 10.1016/0304-3940(85)90056-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Thyrotropin-releasing hormone (TRH) counteracts neuronal damage induced by a substance P antagonist.

Authors:  J Freedman; T Hökfelt; G Jonsson; C Post
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

2.  Spinal action of neurokinins producing cardiovascular responses in the conscious freely moving rat: evidence for a NK-1 receptor mechanism.

Authors:  H Hasséssian; G Drapeau; R Couture
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

3.  Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormone.

Authors:  J Freedman; T Hökfelt; C Post; E Brodin; E Sundström; G Jonsson; L Terenius; S Leander; J A Fischer; A Verhofstad
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

4.  Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity.

Authors:  K Folkers; D M Feng; N Asano; R Håkanson; Z Weisenfeld-Hallin; S Leander
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

5.  The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.

Authors:  T Sakurada; Y Manome; K Tan-No; S Sakurada; K Kisara
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

6.  Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)].

Authors:  O M El-Agnaf; G B Irvine; G Fitzpatrick; W K Glass; D J Guthrie
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

7.  New high affinity peptide antagonists to the spinal galanin receptor.

Authors:  X J Xu; Z Wiesenfeld-Hallin; U Langel; K Bedecs; T Bartfai
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

8.  Effect of spantide, a substance-P antagonist, on cerebral vasospasm in primates.

Authors:  T Delgado-Zygmunt; Y Shiokawa; M A Arbab; N A Svendgaard
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

9.  Spantide III, a superior tachykinin antagonist with high potency and negligible neurotoxicity.

Authors:  K Folkers; R Hakanson; D M Feng; J C Xu; A Janecka; Z Y Wang
Journal:  Amino Acids       Date:  1993-06       Impact factor: 3.520

10.  Autonomic, sensory, and motor dysfunction following intrathecal administration of three substance P antagonists.

Authors:  B F Cox; R L Schelper; F M Faraci; M J Brody
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.